214 related articles for article (PubMed ID: 31875617)
1. Biomarkers for Prediction of Cardiovascular Events in Community-Dwelling Adults Aged 40 or Older.
Chong Y; Ren Q; Li Y; Li C; Feng F; Zhou Y
Int Heart J; 2020 Jan; 61(1):109-114. PubMed ID: 31875617
[TBL] [Abstract][Full Text] [Related]
2. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of lipoprotein-associated phospholipase A
Han L; Zhong C; Bu X; Xu T; Wang A; Peng Y; Xu T; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J;
Atherosclerosis; 2017 Nov; 266():1-7. PubMed ID: 28934604
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China.
Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X
Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599
[TBL] [Abstract][Full Text] [Related]
5. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke.
Elkind MS; Tai W; Coates K; Paik MC; Sacco RL
Arch Intern Med; 2006 Oct; 166(19):2073-80. PubMed ID: 17060536
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction.
Elkind MS; Leon V; Moon YP; Paik MC; Sacco RL
Stroke; 2009 Oct; 40(10):3233-7. PubMed ID: 19644070
[TBL] [Abstract][Full Text] [Related]
7. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
8. The Use of Lipoprotein-Associated Phospholipase A2 in a Chinese Population to Predict Cardiovascular Events.
Xi H; Cheng GL; Hu FF; Li SN; Deng X; Zhou Y
Biomed Environ Sci; 2022 Mar; 35(3):206-214. PubMed ID: 35317900
[TBL] [Abstract][Full Text] [Related]
9. Association between the serum lipoprotein-associated phospholipase A
Dong L; Tong J; Fan S
Cardiovasc J Afr; 2023 Nov-Dec 23; 34(5):273-277. PubMed ID: 36637451
[TBL] [Abstract][Full Text] [Related]
10. Association between high-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2 and carotid atherosclerosis: A cross-sectional study.
Liu H; Yao Y; Wang Y; Ji L; Zhu K; Hu H; Chen J; Yang J; Cui Q; Geng B; Liu Q; Li D; Zhou Y
J Cell Mol Med; 2018 Oct; 22(10):5145-5150. PubMed ID: 30094934
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
[TBL] [Abstract][Full Text] [Related]
12. Improvement in stroke risk prediction: role of C-reactive protein and lipoprotein-associated phospholipase A2 in the women's health initiative.
Wassertheil-Smoller S; McGinn A; Allison M; Ca T; Curb D; Eaton C; Hendrix S; Kaplan R; Ko M; Martin LW; Xue X
Int J Stroke; 2014 Oct; 9(7):902-9. PubMed ID: 23088183
[TBL] [Abstract][Full Text] [Related]
13. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
[TBL] [Abstract][Full Text] [Related]
14. Endothelial function after ST-elevation myocardial infarction in patients with high levels of high-sensitivity CRP and Lp-PLA
Kandhai-Ragunath JJ; de Wagenaar B; Doelman C; van Es J; Jørstad HT; Peters RJG; Doggen CJM; von Birgelen C
Cardiovasc Revasc Med; 2017; 18(3):202-206. PubMed ID: 28110894
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.
Garg PK; McClelland RL; Jenny NS; Criqui MH; Greenland P; Rosenson RS; Siscovick DS; Jorgensen N; Cushman M
Atherosclerosis; 2015 Jul; 241(1):176-82. PubMed ID: 26004387
[TBL] [Abstract][Full Text] [Related]
16. Severe periodontitis is associated with the serum levels of hypersensitive C reactive protein and lipoprotein-associated phospholipase A2 in the patients of acute ischemic stroke.
Chen C; Zhu J; Deng X; Yang Z; Lin W; Ma Y; Huang S; Chen L; Liu Y; Zhu F
J Clin Neurosci; 2021 Jun; 88():232-236. PubMed ID: 33992190
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany.
Koenig W; Khuseyinova N; Löwel H; Trischler G; Meisinger C
Circulation; 2004 Oct; 110(14):1903-8. PubMed ID: 15451783
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study.
Daniels LB; Laughlin GA; Sarno MJ; Bettencourt R; Wolfert RL; Barrett-Connor E
J Am Coll Cardiol; 2008 Mar; 51(9):913-9. PubMed ID: 18308160
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study.
Tsimikas S; Willeit J; Knoflach M; Mayr M; Egger G; Notdurfter M; Witztum JL; Wiedermann CJ; Xu Q; Kiechl S
Eur Heart J; 2009 Jan; 30(1):107-15. PubMed ID: 19019993
[TBL] [Abstract][Full Text] [Related]
20. Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction.
Mody P; Joshi PH; Khera A; Ayers CR; Rohatgi A
J Am Coll Cardiol; 2016 May; 67(21):2480-7. PubMed ID: 27230043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
